Mayo Clinic's blood disorder specialists (hematologists) and cancer specialists (oncologists) are involved in developing new treatments for chronic myelogenous leukemia (CML), including new drugs, biological therapies and chemotherapy options that inhibit the growth of leukemia cells.
Read more about hematology research at Mayo Clinic on the Hematologic Malignancies Program research page.
See a list of publications by Mayo Clinic doctors on chronic myelogenous leukemia on PubMed, a service of the National Library of Medicine.
Read about related research by Mayo Clinic scientific investigators.
Find Mayo Clinic on